These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19235584)

  • 41. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
    Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
    Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
    Chen F; Wang T; Wang J; Wang ZQ; Qian M
    Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differential expression of RPL6/Taxreb107 in drug resistant gastric cancer cell line SGC7901/ADR and its correlation with multiple-drug resistance].
    Du JP; Jin XH; Shi YQ; Cao YX; Zhao YQ; Liu CJ; Yin F; Hu WH; Chen BJ; Qiao TD; Fan DM
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):21-5. PubMed ID: 12678981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular mechanisms of multidrug resistance of tumor cells.
    Stavrovskaya AA
    Biochemistry (Mosc); 2000 Jan; 65(1):95-106. PubMed ID: 10702644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The reversion effect of the RNAi-silencing mdr1 gene on multidrug resistance of the leukemia cell HT9.
    Shao SL; Sun YY; Li XY; Zhang WW; Fu B; Yun DZ; Zuo MX
    Cell Biol Int; 2008 Aug; 32(8):893-8. PubMed ID: 18499486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy.
    Monden N; Abe S; Hishikawa Y; Yoshimura H; Kinugasa S; Dhar DK; Tachibana M; Nagasue N
    Int J Surg Investig; 1999; 1(1):3-10. PubMed ID: 11817335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
    Pop I; Pop L; Vitetta ES; Ghetie MA
    Oncol Rep; 2008 Apr; 19(4):889-95. PubMed ID: 18357372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reversal effect and mechanism of arsenic trioxide on multidrug resistance of gastric carcinoma cells SGC7901].
    Xue YW; Han JG; Li BX; Yang BF
    Yao Xue Xue Bao; 2007 Sep; 42(9):949-53. PubMed ID: 18050736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes.
    Schumacher G; Hoffmann J; Cramer T; Spinelli A; Jacob D; Bahra M; Pratschke J; Pfitzmann R; Schmidt S; Lage H
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1469-73. PubMed ID: 17645459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
    Zhao Y; Bu L; Yan H; Jia W
    Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells.
    Shi Y; Han Y; Wang X; Zhao Y; Ning X; Xiao B; Fan D
    Gastric Cancer; 2002; 5(3):154-9. PubMed ID: 12378342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1.
    Hong L; Wang J; Zhao Y; Han Z; Zhou X; Guo W; Zhang X; Jin H; Wu K; Ding J; Fan D
    Cancer Invest; 2007 Dec; 25(8):699-705. PubMed ID: 18058465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
    Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
    Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
    Fuchs D; Heinold A; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2009 Dec; 390(3):743-9. PubMed ID: 19835841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line.
    Wang CH; Zheng WB; Qiang O; Tang CW
    J Dig Dis; 2009 May; 10(2):91-8. PubMed ID: 19426390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversal of multidrug resistance of gastric cancer cells by down-regulation of ZNRD1 with ZNRD1 siRNA.
    Hong L; Ning X; Shi Y; Shen H; Zhang Y; Lan M; Liang S; Wang J; Fan D
    Br J Biomed Sci; 2004; 61(4):206-10. PubMed ID: 15649014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of SILA-409, a new organosilicon multidrug resistance modifier, on human pancreatic cancer xenografts.
    Zalatnai A; Molnár J
    In Vivo; 2006; 20(1):137-40. PubMed ID: 16433042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
    Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
    Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.